Jingjing Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jingjing Yang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Yujun Song
Division of Colorectal Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing 210023, China
5 shared publications Dongtao Zhou
Department of Gastric and Hernia Surgery, Nanjing Drum Tower Hospital, College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science
3 shared publicationsKunguo Liu
The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
3 shared publicationsShiyu Du
College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing 210023, China
3 shared publications- Xin Han
Nanjing University of Chinese Medicine
3 shared publications Zhibin Zhang
College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing 210023, China
3 shared publications
Latest Publications
- 13 April 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (16) , 12450-12465
Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring
Accurate, real-time, noninvasive longitudinal diagnostic tools are essential for guiding personalized cancer therapy, and urine-based platforms represent a promising noninvasive avenue for continuous therapeutic monitoring. However, conventional approaches relying on passive detection of tumor-derived biomarkers shed into urine are often limited by physiological instability, low abundance, and poor specificity. Herein, we present a dual-enzyme-powered nanosensor for urine-based diagnostics that integrates apurinic/apyrimidinic endonuclease 1 (APE1)-triggered strand cleavage and telomerase (TE)-mediated extension to amplify the signal, enabling visual detection of tumor-associated enzymatic activity via a lateral flow assay (LFA). The nanosensor is constructed by assembling gold nanoclusters (AuNCs) with a synthetic DNA probe (A1T2) and encapsulating the complex with hyaluronic acid (HA). The AuNCs exhibit intrinsic fluorescence and enhanced DNA stability, thereby enabling structural integrity and real-time monitoring. The A1T2 strand is engineered with recognition motifs for APE1 and TE, which mediate sequential DNA cleavage and extension under pathological enzyme overexpression. Upon activation, the nanosensor is enzymatically processed, leaving a AuNC-tagged short single strand that is excreted into urine and detected by a competitive LFA strategy. This enables direct, visual, and instrument-free readout. The synergistic action of APE1 and TE confers a competitive advantage on the DNA substrate, leading to enhanced chromogenic shifts on test strips and improved visual resolution. This strategy translates intracellular enzyme activity into stable urinary signals and demonstrates the potential for low-cost, instrument-free companion diagnostics for personalized cancer treatment.
- 13 April 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (16) , 12450-12465
Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring
Accurate, real-time, noninvasive longitudinal diagnostic tools are essential for guiding personalized cancer therapy, and urine-based platforms represent a promising noninvasive avenue for continuous therapeutic monitoring. However, conventional approaches relying on passive detection of tumor-derived biomarkers shed into urine are often limited by physiological instability, low abundance, and poor specificity. Herein, we present a dual-enzyme-powered nanosensor for urine-based diagnostics that integrates apurinic/apyrimidinic endonuclease 1 (APE1)-triggered strand cleavage and telomerase (TE)-mediated extension to amplify the signal, enabling visual detection of tumor-associated enzymatic activity via a lateral flow assay (LFA). The nanosensor is constructed by assembling gold nanoclusters (AuNCs) with a synthetic DNA probe (A1T2) and encapsulating the complex with hyaluronic acid (HA). The AuNCs exhibit intrinsic fluorescence and enhanced DNA stability, thereby enabling structural integrity and real-time monitoring. The A1T2 strand is engineered with recognition motifs for APE1 and TE, which mediate sequential DNA cleavage and extension under pathological enzyme overexpression. Upon activation, the nanosensor is enzymatically processed, leaving a AuNC-tagged short single strand that is excreted into urine and detected by a competitive LFA strategy. This enables direct, visual, and instrument-free readout. The synergistic action of APE1 and TE confers a competitive advantage on the DNA substrate, leading to enhanced chromogenic shifts on test strips and improved visual resolution. This strategy translates intracellular enzyme activity into stable urinary signals and demonstrates the potential for low-cost, instrument-free companion diagnostics for personalized cancer treatment.
- Open Access
- 14 August 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (39) , 9795-9820
Nanomaterial combined engineered bacteria for intelligent tumor immunotherapy
Compared to traditional therapies, tumor immunotherapy has received a lot of attention and research focus due to its potential to activate both innate and adaptive immunity, cause low toxicity to normal tissue, and induce long-term immune activity.
- 14 August 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (39) , 9795-9820
Open AccessNanomaterial combined engineered bacteria for intelligent tumor immunotherapy
Compared to traditional therapies, tumor immunotherapy has received a lot of attention and research focus due to its potential to activate both innate and adaptive immunity, cause low toxicity to normal tissue, and induce long-term immune activity.
- 13 August 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 374, 127-139
Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy
- 13 August 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 374, 127-139
Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy
- 25 July 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (31) , 40499-40514
Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors
Crohn's disease (CD) is a refractory chronic inflammatory bowel disease (IBD) with unknown etiology. Transmural inflammation, involving the intestine and mesentery, represents a characteristic pathological feature of CD and serves as a critical contributor to its intractability. Here, this study describes an oral pyroptosis nanoinhibitor loaded with tumor necrosis factor-alpha (TNF-alpha) deoxyribozymes (DNAzymes) (DNAzymes@degradable silicon nanoparticles@Mannose, Dz@MDSN), which can target macrophages at the site of inflammation and respond to reactive oxygen species (ROS) to release drugs. Dz@MDSN can not only break the inflammatory cycle in macrophages by degrading TNF-alpha mRNA but also reduce the production of ROS mainly from macrophages. Moreover, Dz@MDSN inhibits excessive pyroptosis in epithelial cells through ROS clearance, thereby repairing the intestinal barrier and reducing the translocation of intestinal bacteria to the mesentery. Consequently, these combined actions synergistically contribute to the suppression of inflammation within both the intestine and the mesentery. This study likely represents the first successful attempt in the field of utilizing nanomaterials to achieve transmural healing for CD, which also provides a promising treatment strategy for CD patients.
- 25 July 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (31) , 40499-40514
Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors
Crohn's disease (CD) is a refractory chronic inflammatory bowel disease (IBD) with unknown etiology. Transmural inflammation, involving the intestine and mesentery, represents a characteristic pathological feature of CD and serves as a critical contributor to its intractability. Here, this study describes an oral pyroptosis nanoinhibitor loaded with tumor necrosis factor-alpha (TNF-alpha) deoxyribozymes (DNAzymes) (DNAzymes@degradable silicon nanoparticles@Mannose, Dz@MDSN), which can target macrophages at the site of inflammation and respond to reactive oxygen species (ROS) to release drugs. Dz@MDSN can not only break the inflammatory cycle in macrophages by degrading TNF-alpha mRNA but also reduce the production of ROS mainly from macrophages. Moreover, Dz@MDSN inhibits excessive pyroptosis in epithelial cells through ROS clearance, thereby repairing the intestinal barrier and reducing the translocation of intestinal bacteria to the mesentery. Consequently, these combined actions synergistically contribute to the suppression of inflammation within both the intestine and the mesentery. This study likely represents the first successful attempt in the field of utilizing nanomaterials to achieve transmural healing for CD, which also provides a promising treatment strategy for CD patients.
- 6 June 2024
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 160 (21)
Unsaturation effects on lipid transmembrane asymmetry
Within cell plasma membranes, unsaturated lipids are asymmetrically distributed over the inner and outer leaflets, offering an attractive local structural feature. However, the mechanism to keep lipid transmembrane asymmetry and the closely related transmembrane movement (flip-flop) for unsaturated lipids remain poorly understood. Here, we applied sum frequency generation vibrational spectroscopy to investigate this lipid transmembrane asymmetry upon mimicking the cell membrane homeostatic processes. On the one hand, unsaturated lipids were found to hinder the flip-flop process and preserve lipid transmembrane asymmetry in model cell membranes, owing to the steric hindrance caused by their bent tails. On the other hand, local unsaturated lipids in the mixed unsaturated/saturated lipid bilayer were conducive to the formation of the local asymmetry. Therefore, lipid unsaturation can be recognized as an intrinsic key factor to form and maintain lipid transmembrane asymmetry in cell membranes.
- 6 June 2024
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 160 (21)
Unsaturation effects on lipid transmembrane asymmetry
Within cell plasma membranes, unsaturated lipids are asymmetrically distributed over the inner and outer leaflets, offering an attractive local structural feature. However, the mechanism to keep lipid transmembrane asymmetry and the closely related transmembrane movement (flip-flop) for unsaturated lipids remain poorly understood. Here, we applied sum frequency generation vibrational spectroscopy to investigate this lipid transmembrane asymmetry upon mimicking the cell membrane homeostatic processes. On the one hand, unsaturated lipids were found to hinder the flip-flop process and preserve lipid transmembrane asymmetry in model cell membranes, owing to the steric hindrance caused by their bent tails. On the other hand, local unsaturated lipids in the mixed unsaturated/saturated lipid bilayer were conducive to the formation of the local asymmetry. Therefore, lipid unsaturation can be recognized as an intrinsic key factor to form and maintain lipid transmembrane asymmetry in cell membranes.
- 24 August 2023
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 23 (17) , 8081-8090
Deep Tumor Penetration of CRISPR-Cas System for Photothermal-Sensitized Immunotherapy via Probiotics
Since central cells are more malignant and aggressive in solid tumors, improving penetration of therapeutic agents and activating immunity in tumor centers exhibit great potential in cancer therapies. Here, polydopamine-coated Escherichia coli Nissle 1917 (EcN) bearing CRISPR-Cas9 plasmid-loaded liposomes (Lipo-P) are applied for enhanced immunotherapy in deep tumors through activation of innate and adaptive immunity simultaneously. After accumulation in the tumor center through hypoxia targeting, Lipo-P could be detached under the reduction of reactive oxygen species (ROS)-responsive linkers, lowering the thermal resistance of cancer cells via Hsp90α depletion. Owing to that, heating induced by polydopamine upon near-infrared irradiation could achieve effective tumor ablation. Furthermore, mild photothermal therapy induces immunogenic cell death, as bacterial infections in tumor tissues trigger innate immunity. This bacteria-assisted approach provides a promising photothermal-sensitized immunotherapy in deep tumors.
- 24 August 2023
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 23 (17) , 8081-8090
Deep Tumor Penetration of CRISPR-Cas System for Photothermal-Sensitized Immunotherapy via Probiotics
Since central cells are more malignant and aggressive in solid tumors, improving penetration of therapeutic agents and activating immunity in tumor centers exhibit great potential in cancer therapies. Here, polydopamine-coated Escherichia coli Nissle 1917 (EcN) bearing CRISPR-Cas9 plasmid-loaded liposomes (Lipo-P) are applied for enhanced immunotherapy in deep tumors through activation of innate and adaptive immunity simultaneously. After accumulation in the tumor center through hypoxia targeting, Lipo-P could be detached under the reduction of reactive oxygen species (ROS)-responsive linkers, lowering the thermal resistance of cancer cells via Hsp90α depletion. Owing to that, heating induced by polydopamine upon near-infrared irradiation could achieve effective tumor ablation. Furthermore, mild photothermal therapy induces immunogenic cell death, as bacterial infections in tumor tissues trigger innate immunity. This bacteria-assisted approach provides a promising photothermal-sensitized immunotherapy in deep tumors.
- Open Access
- 22 December 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (6) , 2510-2543
Intelligent nanotherapeutic strategies for the delivery of CRISPR system
- 22 December 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (6) , 2510-2543
Open AccessIntelligent nanotherapeutic strategies for the delivery of CRISPR system
- Open Access
- 24 November 2022
- Published by Springer Nature in Nano Convergence
- Vol. 9 (1) , 1-15
Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy
Chemoresistance remains a huge challenge for effective treatment of non-small cell lung cancer (NSCLC). Previous studies have shown Chinese herbal extracts possess great potential in ameliorating tumor chemoresistance, however, the efficacy is clinically limited mainly because of the poor tumor-targeting and in vivo stability. The construction of nano-delivery systems for herbal extracts has been shown to improve drug targeting, enhance therapeutic efficacy and reduce toxic and side effects. In this study, a folic acid (FA)-modified nano-herb micelle was developed for codelivery of pristimerin (PRI) and paclitaxel (PTX) to enhance chemosensitivity of NSCLC, in which PRI could synergistically enhance PTX-induced growth inhibition of A549 cancer cell. PTX was firstly grafted with the FA-linked polyethylene glycol (PEG) and then encapsulated with PRI to construct the PRI@FA-PEG-PTX (P@FPP) nano-micelles (NMs), which exhibited improved tumor-targeting and in vivo stability. This active-targeting P@FPP NMs displayed excellent tumor-targeting characteristics without obvious toxicity. Moreover, inhibition of tumor growth and metastasis induced by P@FPP NMs were significantly enhanced compared with the combined effects of the two drugs (PRI in combination of PTX), which associated with epithelial mesenchymal transition inhibition to some extent. Overall, this active-targeting NMs provides a versatile nano-herb strategy for improving tumor-targeting of Chinese herbal extracts, which may help in the promotion of enhancing chemosensitivity of NSCLC in clinical applications.
- 24 November 2022
- Published by Springer Nature in Nano Convergence
- Vol. 9 (1) , 1-15
Open AccessAccurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy
Chemoresistance remains a huge challenge for effective treatment of non-small cell lung cancer (NSCLC). Previous studies have shown Chinese herbal extracts possess great potential in ameliorating tumor chemoresistance, however, the efficacy is clinically limited mainly because of the poor tumor-targeting and in vivo stability. The construction of nano-delivery systems for herbal extracts has been shown to improve drug targeting, enhance therapeutic efficacy and reduce toxic and side effects. In this study, a folic acid (FA)-modified nano-herb micelle was developed for codelivery of pristimerin (PRI) and paclitaxel (PTX) to enhance chemosensitivity of NSCLC, in which PRI could synergistically enhance PTX-induced growth inhibition of A549 cancer cell. PTX was firstly grafted with the FA-linked polyethylene glycol (PEG) and then encapsulated with PRI to construct the PRI@FA-PEG-PTX (P@FPP) nano-micelles (NMs), which exhibited improved tumor-targeting and in vivo stability. This active-targeting P@FPP NMs displayed excellent tumor-targeting characteristics without obvious toxicity. Moreover, inhibition of tumor growth and metastasis induced by P@FPP NMs were significantly enhanced compared with the combined effects of the two drugs (PRI in combination of PTX), which associated with epithelial mesenchymal transition inhibition to some extent. Overall, this active-targeting NMs provides a versatile nano-herb strategy for improving tumor-targeting of Chinese herbal extracts, which may help in the promotion of enhancing chemosensitivity of NSCLC in clinical applications.
- 1 October 2021
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 345, 130382
Copper metal-organic framework incorporated mesoporous silica as a bioorthogonal biosensor for detection of glutathione
- 1 October 2021
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 345, 130382
Copper metal-organic framework incorporated mesoporous silica as a bioorthogonal biosensor for detection of glutathione
- Open Access
- 5 April 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (4) , eaav7199
Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform
As an RNA-guided nuclease, CRISPR-Cas9 offers facile and promising solutions to mediate genome modification with respect to versatility and high precision. However, spatiotemporal manipulation of CRISPR-Cas9 delivery remains a daunting challenge for robust effectuation of gene editing both in vitro and in vivo. Here, we designed a near-infrared (NIR) light–responsive nanocarrier of CRISPR-Cas9 for cancer therapeutics based on upconversion nanoparticles (UCNPs). The UCNPs served as “nanotransducers” that can convert NIR light (980 nm) into local ultraviolet light for the cleavage of photosensitive molecules, thereby resulting in on-demand release of CRISPR-Cas9. In addition, by preparing a single guide RNA targeting a tumor gene (polo-like kinase-1), our strategies have successfully inhibited the proliferation of tumor cell via NIR light–activated gene editing both in vitro and in vivo. Overall, this exogenously controlled method presents enormous potential for targeted gene editing in deep tissues and treatment of a myriad of diseases.
- 5 April 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (4) , eaav7199
Open AccessNear-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform
As an RNA-guided nuclease, CRISPR-Cas9 offers facile and promising solutions to mediate genome modification with respect to versatility and high precision. However, spatiotemporal manipulation of CRISPR-Cas9 delivery remains a daunting challenge for robust effectuation of gene editing both in vitro and in vivo. Here, we designed a near-infrared (NIR) light–responsive nanocarrier of CRISPR-Cas9 for cancer therapeutics based on upconversion nanoparticles (UCNPs). The UCNPs served as “nanotransducers” that can convert NIR light (980 nm) into local ultraviolet light for the cleavage of photosensitive molecules, thereby resulting in on-demand release of CRISPR-Cas9. In addition, by preparing a single guide RNA targeting a tumor gene (polo-like kinase-1), our strategies have successfully inhibited the proliferation of tumor cell via NIR light–activated gene editing both in vitro and in vivo. Overall, this exogenously controlled method presents enormous potential for targeted gene editing in deep tissues and treatment of a myriad of diseases.